Eltrombopag Olamine: A Key Pharmaceutical Agent
Explore the therapeutic potential and chemical significance of Eltrombopag Olamine in modern medicine.
Get a Quote & SampleProduct Core Value
Eltrombopag Olamine
Eltrombopag Olamine is a vital pharmaceutical intermediate, recognized for its role as an orally active thrombopoietin receptor agonist. It plays a crucial role in stimulating megakaryocyte proliferation and differentiation, thereby increasing platelet counts. Its application is critical in treating conditions like thrombocytopenia associated with chronic immune thrombocytopenia and hepatitis C, as well as severe aplastic anemia. Understanding the Eltrombopag Olamine chemical properties is key to its effective use.
- Eltrombopag Olamine CAS 496775-62-3 uses extend to managing low platelet counts in various medical conditions.
- The eltrombopag olamine pharmaceutical applications are diverse, ranging from direct therapeutic use to its role as an API.
- As a potent thrombopoietin receptor agonist, it directly influences the body's platelet production mechanisms.
- The treatment of thrombocytopenia with eltrombopag has shown significant efficacy in clinical studies.
Advantages Provided by Eltrombopag Olamine
Therapeutic Efficacy
This compound demonstrates significant efficacy in treating thrombocytopenia, a condition characterized by low platelet counts, improving patient outcomes in aplastic anemia and hepatitis C related conditions.
Mechanism of Action
Leveraging its role as a thrombopoietin receptor agonist, it precisely targets the pathways responsible for platelet generation, offering a targeted treatment approach.
Research and Development Potential
The compound is pivotal in ongoing research, with extensive eltrombopag clinical trials continuously exploring its broader therapeutic capabilities and market potential.
Key Applications
Pharmaceutical Medicine
Eltrombopag Olamine is a key ingredient in pharmaceutical preparations designed to manage bleeding disorders and improve blood cell counts, crucial for patients undergoing various medical treatments.
Research Chemical
As a critical research chemical, it aids in understanding thrombopoiesis and exploring new therapeutic strategies for hematological disorders, contributing to advancements in medical science.
API Intermediate
Its use as an Active Pharmaceutical Ingredient (API) intermediate underscores its importance in the synthesis of advanced therapeutics, supporting the eltrombopag olamine buy and eltrombopag olamine price discussions.
Hematological Disorder Treatment
The compound is fundamental for treating low blood platelet counts, offering hope and improved quality of life for patients suffering from conditions like immune thrombocytopenia.